๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors
NCT07299747Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc
Phase 1/2
255
Shanghai
2025-12-04
Recruiting
Association Between Clinical Classification and Prognosis in Chronic Radiation Enteropathy
NCT07378631Radiotherapy, Radiation Proctitis, Radiation Enteritis
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
150
Guangzhou
2025-12-04
Recruiting
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
NCT07283315Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
12
Hangzhou
2025-12-03
Recruiting
First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
NCT07285889Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University
Phase 1/2
35
Hangzhou
2025-12-03
Recruiting
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
NCT07284927Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1
10
Suzhou
2025-12-03
Recruiting
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
NCT07371663Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer), Gastric (Stomach) Cancer, Endometrial Cancer
Beijing Tide Pharmaceutical Co., Ltd
Phase 1/2
266
Beijing, Zhengzhou, Hangzhou
2025-12-03
Recruiting
A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181
NCT07446816Advanced Solid Tumors
Ganzhou Hemay Pharmaceutical Co., Ltd
Phase 1
24
Xinxiang
2025-12-03
Recruiting
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07244341Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo
Phase 1
60
Guangzhou, Shanghai, Wenzhou
2025-12-03
Recruiting
Serplulimab for Locally Advanced Cervical Cancer
NCT07340489Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
216
Tianjin
2025-12-03
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
NCT07276399Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC
Phase 3
500
Beijing, Bengbu, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Hangzhou
2025-12-03
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
NCT07218926Gastrointestinal Neoplasms
GlaxoSmithKline
Phase 3
450
Shijiazhuang, Shanghai, Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan
2025-12-03
Recruiting
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT07265284Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
104
Beijing
2025-12-03
Recruiting
Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke
NCT07540741Acute Ischemic Stroke
First Affiliated Hospital of Harbin Medical University
Observational
1,000
Heilongjiang
2025-12-03
Recruiting
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
NCT06979453Plaque Psoriasis
Bristol-Myers Squibb
Phase 3
366
Beijing, Guangzhou, Shenzhen, Handan, Zhengzhou, Changsha, Jinan, Shanghai
2025-12-03
Recruiting
A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
NCT07229612Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
200
Guangzhou
2025-12-03
Recruiting
Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting
NCT07247864Carotid Artery Stenosis
Beijing Anzhen Hospital
Not applicable
296
Beijing
2025-12-03
Recruiting
A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
NCT07487727Anemia Due to Chronic Kidney Disease
Kind Pharmaceuticals LLC
Phase 3
240
Beijing
2025-12-03
Recruiting
Influenza Vaccination After Acute Coronary Syndrome
NCT07259252Acute Coronary Syndromes (ACS)
Tongji Hospital
Not applicable
6,620
Wuhan
2025-12-03
Recruiting
PTC-Guided Therapy for Peritoneal Mesothelioma
NCT07330271Peritoneal Mesothelioma
Beijing Tsinghua Chang Gung Hospital
Not applicable
347
Beijing
2025-12-02
Not yet open
Auricular Acupressure Reduces Rebound Effects After Discontinuation of Atropine
NCT07129889Myopia
Ningbo Eye Hospital
Not applicable
180
Ningbo
2025-12-02
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281Atopic Dermatitis
Pfizer
Phase 3
500
Beijing, Shenzhen, Changsha, Nanchang, Hangzhou, Shanghai
2025-12-02
Recruiting
Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
NCT07238283First-line Treatment of Metastatic Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
662
Beijing
2025-12-02
Recruiting
Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma
NCT07099547Biliary Tract Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2
60
Hefei
2025-12-02
Recruiting
A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
NCT07771140HBV Infection
Sunshine Lake Pharma Co., Ltd.
Phase 1
78
Hefei
2025-12-02
Active, closed
A Study of DII235 in Adults With Elevated Lipoprotein(a)
NCT07235046Lipoprotein Disorder
Novartis Pharmaceuticals
Phase 2
234
Luoyang, Shenyang, Wenzhou, Beijing
2025-12-02
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229Alzheimer Disease, Agitation
Bristol-Myers Squibb
Phase 3
650
Beijing, Haidian District, Guangzhou, Shenzhen, Changsha, Nanjing, Tianjin, Hangzhou
2025-12-02
Recruiting
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
NCT07229586Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
100
Tianjin
2025-12-02
Not yet open
For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.
NCT07264881Microvascular Obstruction (MVO), Multivessel Coronary Artery Disease, ACS (Acute Coronary Syndrome), ST Elevation Myocardial Infarction (STEMI)
Beijing Anzhen Hospital
Observational
200
Beijing
2025-12-02
Recruiting
A Randomized Trial of Ultrasound-Guided Acupotomy for Ankylosing Spondylitis
NCT07578220Ankylosing Spondylitis
China-Japan Friendship Hospital
Not applicable
60
Henan
2025-12-02
Recruiting
Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission
NCT07300254Syphilis
Monash University
Observational
480
Shanghai
2025-12-02
Recruiting
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
NCT07165951Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
566
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Shenzhen
2025-12-02
Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
NCT07116031Chronic Graft Versus Host Disease
Sanofi
Phase 2
37
Beijing, Shanghai, Shenzhen, Suzhou
2025-12-02
Recruiting
A Study of LBL-024 in Combination With Paclitaxel ยฑ Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer
NCT07042802Ovarian Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
180
Beijing, Fuzhou, Guangzhou, Harbin, Anyang, Zhengzhou, Xuzhou, Shenyang
2025-12-02
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558Rheumatoid Arthritis, Systemic Lupus Erythematosus
AstraZeneca
Phase 1
48
Beijing, Chengdu, Nanjing
2025-12-02
Not yet open
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
NCT07189910Primary Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
150
Wuhan
2025-12-01
Recruiting
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
NCT07392346Gastric Cancer Adenocarcinoma Metastatic
Dai, Guanghai
Phase 2
68
Beijing
2025-12-01
By invitation
Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
NCT07448233Epilepsies, Remote Management of Epilepsy in Rural Areas
Xijing Hospital
Not applicable
20
Xi'an
2025-12-01
Recruiting
Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease
NCT07363538Complex Congenital Heart Disease
Central China Fuwai Hospital of Zhengzhou University
Not applicable
738
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Qingdao
2025-12-01
Active, closed
Neuromuscular Rehab for ACL Reconstruction: Knee Function & Brain Plasticity
NCT07243860Anterior Cruciate Ligament Injuries
Peking University Third Hospital
Not applicable
50
Beijing
2025-12-01
Recruiting
Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis
NCT07413068Cholelithiasis Associated With Common Bile Duct Stones
Qilu Hospital of Shandong University
Observational
300
Jinan
2025-12-01
Recruiting
Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC
NCT07626736Nonsmall Cell Lung Cancer
Wen-zhao ZHONG
Not applicable
300
Guangzhou
2025-12-01
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)
NCT07347028Myofascial Trigger Points, Migraine, Cervicogenic Headache, Chronic Musculoskeletal Pain
Beijing Tiantan Hospital
Not applicable
1,036
Beijing
2025-12-01
Recruiting
Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL
NCT07278882Pediatric Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
100
Tianjin
2025-12-01
Recruiting
A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma
NCT07306299Glioma, High Grade
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
10
Hangzhou
2025-12-01
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA)
NCT07347041Myofascial Trigger Points, Chronic Musculoskeletal Pain, Hip Osteoarthritis
Beijing Tiantan Hospital
Not applicable
1,036
Beijing
2025-12-01
Not yet open
High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study
NCT07227545Alcohol Use Disorder (AUD)
Shanghai Mental Health Center
Not applicable
18
Shanghai
2025-12-01
Not yet open
Dose-escalation of Rectal Indomethacin for Preventing PEP
NCT07247682Post-ERCP Pancreatitis
The First Affiliated Hospital of Anhui Medical University
Phase 4
1,036
Hefei
2025-12-01
Recruiting
Asiaticoside for Treating Overweight/Obesity
NCT07241533Overweight , Obesity
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2025-12-01
Not yet open
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
NCT07261592Bladder Cancer, Histone Deacetylase Inhibitor, Entinostat, Chemotherapy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
29
Nanjing
2025-12-01
Active, closed
AI Multimodal Model for Liver Cancer Diagnosis and Prognosis
NCT07658586Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma (Icc)
Guangxi Medical University
Observational
600
Nanning
2025-12-01
Not yet open
Effect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney Disease
NCT07268807Heart Failure, CKD, Anemia
Zhongda Hospital
Observational
200
Nanjing
2025-12-01
Not yet open
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
NCT07277504B-Cell Acute Lymphoblastic Leukemia, Adult
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
50
Chengdu
2025-12-01
Recruiting
Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression
NCT07670026Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
31
Hangzhou
2025-12-01
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)
NCT07347054Myofascial Trigger Points, Chronic Musculoskeletal Pain, Shoulder Osteoarthritis
Beijing Tiantan Hospital
Not applicable
1,036
Beijing
2025-12-01
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
NCT07305116Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
15
Hangzhou
2025-12-01
Recruiting
Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty
NCT07319546Knee Osteoarthristis, Arthroplasties, Knee Replacement
Mahidol University
Not applicable
32
Dali
2025-12-01
Active, closed
Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol
NCT07257497Solid Tumor Cancer
West China Hospital
Phase 1
20
Chengdu
2025-12-01
Not yet open
The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder
NCT04534907Obsessive-Compulsive Disorder, Virtual Reality
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-12-01
Recruiting
Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia
NCT07263906Refractory Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hangzhou
2025-12-01
Recruiting
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
NCT07644286Colorectal Cancer (CRC)
Tao Zhang
Phase 2
48
Wuhan
2025-12-01
Recruiting
The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain
NCT07367672Healthy Participants
University of Electronic Science and Technology of China
Not applicable
120
Chengdu
2025-12-01
Recruiting
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer๏ผˆNSCLC๏ผ‰
NCT07388771NSCLC, Neoadjuvant Therapy
Qian Chu
Observational
500
Wuhan, Hangzhou
2025-12-01
Not yet open
Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma
NCT07249125Papillary Thyroid Microcarcinoma
Xijing Hospital
Observational
1,630
Xi'an
2025-12-01
Recruiting
Niaoduqing Granules in Older Adults With Impaired Kidney Function
NCT07741292Chronic Kidney Disease
Huashan Hospital
Phase 4
300
Shanghai
2025-12-01
Recruiting
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation
NCT07648992Hematopoietic Stem Cell Transplantation
Daihong Liu
Phase 4
324
Beijing
2025-12-01
Recruiting
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
NCT06514508Multiple Myeloma
Guangzhou Gloria Biosciences Co., Ltd.
Phase 3
60
Beijing, Harbin
2025-12-01
Recruiting
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
NCT07458906DLL3-expressing Tumors, PET / CT, Neuroendocrine Cancer
The First Affiliated Hospital of Xiamen University
Not applicable
60
Xiamen
2025-12-01
Recruiting
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
NCT07216014Crohn's Disease and Ulcerative Colitis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 4
200
Guangzhou
2025-12-01
Not yet open
A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy
NCT07257003Breast Cancer
Du Zhenggui
Not applicable
150
Chengdu
2025-12-01
Recruiting
Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
NCT06958705Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
79
Nanjing
2025-12-01
Not yet open
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
NCT07275853Advanced Solid Tumors
TCRx Therapeutics Co.Ltd
Phase 1
30
Beijing
2025-12-01
Not yet open
Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction
NCT07250152Myocardial Infarction (MI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,544
Hangzhou
2025-12-01
By invitation
Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries
NCT07547254Pressure Ulcer Prevention
Ruijin Hospital
Not applicable
60
Shanghai
2025-12-01
Not yet open
Allogeneic UCB-derived CAR-T for B-ALL
NCT07256353B-Cell Acute Lymphoblastic Leukemia, Adult
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
50
Chengdu
2025-12-01
Recruiting
Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas
NCT07405372Glioma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Observational
10
Chongqing
2025-12-01
Not yet open
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
NCT07244965LOCALLY ADVANCED CERVICAL CANCERS
Women's Hospital School Of Medicine Zhejiang University
Phase 2
42
Hangzhou
2025-12-01
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
NCT07282353Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc
Phase 3
135
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Shenzhen, Zhanjiang, Nanning
2025-12-01
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine
NCT07347067Myofascial Trigger Points, Chronic Migraine Headache, Greater Occipital Nerve Block
Beijing Tiantan Hospital
Not applicable
1,036
Beijing
2025-12-01
By invitation
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
NCT07290764Hepatocellular Carcinoma
Fujian Provincial Hospital
Observational
729
Fuzhou
2025-12-01
Recruiting
Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis
NCT07495111Cholelithiasis Associated With Common Bile Duct Stones
Qilu Hospital of Shandong University
Not applicable
88
Jinan
2025-12-01
Not yet open
RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer
NCT07269691Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer
Pengfei Qiu
Phase 3
194
Jinan
2025-12-01
Recruiting
MPR for Stroke Risk Assessment of ICAS
NCT07309718ICAS - Intracranial Atherosclerosis, Stroke Ischemic, Hemodynamic
Xuanwu Hospital, Beijing
Observational
400
Beijing
2025-12-01
Recruiting
Human Sinonasal Mucosa Heterogeneity Study
NCT07692243Human Sinonasal Mucosal Spatial Atlas
First Affiliated Hospital, Sun Yat-Sen University
Observational
100
Guangzhou
2025-12-01
Recruiting
DEB-TACE vs cTACE in HCC After TIPS
NCT07322848Hepatocellular Carcinoma (HCC), TACE, TIPS, DEB-TACE
First Affiliated Hospital, Sun Yat-Sen University
Phase 3
206
Guangzhou
2025-12-01
Recruiting
Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
NCT07587944AML, Adult
Fujian Medical University Union Hospital
Observational
405
Fuzhou
2025-12-01
Not yet open
Paracetamol and Mannitol Injection and Postoperative Delirium
NCT07235995Postoperative Delirium, Elderly, Non Cardiac Surgery
Xiangya Hospital of Central South University
Phase 4
1,092
Changsha
2025-12-01
Not yet open
A Phase โ… /โ…กa Study of SNUG01 in Adult Subjects With ALS
NCT07169175Amyotrophic Lateral Sclerosis (ALS)
SineuGene Therapeutics Co., Ltd.
Phase 1/2
21
Beijing, Fuzhou, Hangzhou
2025-12-01
Recruiting
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
NCT07436845Hepatocellular Carcinoma (HCC), Emotional Distress, HAIC(Hepatic Artery Infusion Chemotherapy), Immunotherapy
Nanfang Hospital, Southern Medical University
Observational
90
Guangzhou
2025-12-01
Active, closed
AI Chatbots for Anxiety Mental Health Literacy
NCT07316374Anxiety Literacy, Anxiety Disorders, Mental Health Literacy
Peking University
Not applicable
200
Beijing
2025-12-01
Not yet open
Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial
NCT07233317Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
170
Beijing
2025-12-01
Recruiting
Clinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia
NCT07346378Post-stroke Aphasia
The First Affiliated Hospital of Anhui Medical University
Not applicable
40
Hefei
2025-12-01
Recruiting
STROKE 120 ACTION Trial
NCT07135310Ischemic Stroke
Shanghai Minhang Central Hospital
Not applicable
1,696,000
Shanghai
2025-12-01
Recruiting
Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
NCT07297173Relapsed Leukemia, Refractory Leukemia
Beijing 302 Hospital
Phase 1
5
Beijing
2025-12-01
Not yet open
Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS
NCT07261072Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa), Secukinumab
Peking Union Medical College
Phase 4
30
Nanjing
2025-12-01
Recruiting
Diagnostic Value of 68Ga-Pentixafor PET/CT in Adrenal Tumors With Aldosterone and Cortisol Cosecretion
NCT07605156Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Peking University First Hospital
Observational
130
Beijing
2025-12-01
Recruiting
Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
NCT07530094Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Ning Jiang, M.D./Ph.D.
Phase 2
98
Nanjing
2025-12-01
Recruiting
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
NCT07243873Lung Cancer, PET-CT
Shanghai Pulmonary Hospital, Shanghai, China
Observational
10,000
Zunyi, Jiangxi, Shanghai, Ningbo
2025-12-01
Not yet open
A RCT of Moist Ag Dressing in Chronic Wound
NCT07235254Chronic Wound, Hard to Heal Wounds, Dressing, Wound he'a'Ling
Peking University Third Hospital
Not applicable
40
Beijing
2025-12-01
Recruiting
A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
NCT07206745Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
Henan University of Traditional Chinese Medicine
Not applicable
152
Zhengzhou
2025-12-01
Not yet open
Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial
NCT07261709Refractory Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2
236
Guangzhou
2025-12-01
Rows per page Showing 5001–5100 of 19052
Previous 49 50 51 52 53 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=51

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.